Investigation of the antiallergic activity of olopatadine on rhinitis induced by intranasal instillation of antigen in sensitized rats using thermography
10.5415/apallergy.2011.1.3.138
- Author:
Tadafumi TAMURA
1
Author Information
1. Pharmacological Research Laboratories, Research Division, Kyowa Hakko Kirin Co., Ltd., Shizuoka 411-8731, Japan. tadafumi.tamura@kyowa-kirin.co.jp
- Publication Type:Original Article
- Keywords:
Olopatadine;
Antihistamine;
Animal model;
Rhinitis;
Thermography
- MeSH:
Administration, Intranasal;
Animals;
Enzyme-Linked Immunosorbent Assay;
Histamine;
Humans;
Hypersensitivity;
Models, Animal;
Mucous Membrane;
Nasal Lavage Fluid;
Nasal Obstruction;
Nerve Growth Factor;
Nose;
Olopatadine Hydrochloride;
Ovalbumin;
Ovum;
Poaceae;
Pollen;
Rats;
Receptors, Histamine H1;
Rhinitis;
Rhinitis, Allergic;
Skin Temperature;
Sneezing;
Thermography;
Vascular Endothelial Growth Factor A
- From:
Asia Pacific Allergy
2011;1(3):138-144
- CountryRepublic of Korea
- Language:English
-
Abstract:
BACKGROUND: The main symptoms of allergic rhinitis (AR) are sneezing, rhinorrhea and nasal obstruction. It was reported that the nasal skin temperature after intranasal administration of histamine or grass pollen rose. In patients with AR, the levels of nerve growth factor (NGF) and vascular endothelial growth factor (VEGF) have increased in nasal fluids and mucosa. OBJECTIVE: The present study were to determine the temperature changes of the nose in rat allergic rhinitis model, and if olopatadine, an antiallergic agent with histamine H1 receptor antagonistic action, proved to be effective, were studied the productions of NGF and VEGF in nasal lavage fluids (NALF). In the present study, we used ovalbumin (OVA)-sensitized rats as an animal model of nasal allergy and examined the effects of olopatadine on the skin temperature of the nose area, and the productions of NGF and VEGF in NALF. METHODS: The temperature changes of the nose area were carried out with thermo tracer in rat passively sensitized with OVA antiserum. The numbers of sneezing episodes were counted and, NGF and VEGF levels in NALF were examined using the specific ELISA. RESULTS: In OVA-sensitized rats, the number of sneezing episodes increase and the nasal skin temperature rise were provoked after OVA challenge. The levels of NGF and VEGF in NALF also were increased. Olopatadine reduced the increased frequency of sneezing and the nasal skin temperature rise. It also inhibited the increased NGF and VEGF productions in NALF. CONCLUSION: The nasal skin temperature after OVA challenge rose even in OVA-sensitized rats. These results suggest that the suppression of the increased NGF and VEGF levels might partially be involved in the improvement of allergy-like behavior (sneezing and nasal skin temperature rise) by the treatment of olopatadine.
